Target intelligence / Profile preview

Membrane lipids and Free radicals

Molecular classification
Lipid, phospholipid, glycolipid, sterol, Reactive oxygen species (ROS), Reactive nitrogen species (RNS)
01

Overview

Membrane lipids are the primary structural components of biological membranes and consist mainly of phospholipids, glycolipids, and cholesterol. Free radicals, particularly reactive oxygen and nitrogen species, are highly reactive molecules generated during normal metabolism and under stress conditions. Free radicals attack the polyunsaturated fatty acid residues of membrane lipids in a process called lipid peroxidation, leading to decreased membrane fluidity, disruption of cell signaling, damage to proteins and DNA, and ultimately cell death (notably via ferroptosis). This process is implicated in a variety of diseases including neurodegeneration, cancer, cardiovascular disorders, and aging. While individual downstream targets of the lipid peroxidation pathway (such as GPX4) are drug targets, "membrane lipids/free radicals" as stated is too broad to be a canonical therapeutic target[3][4][5][6].

Other names
membrane phospholipidscell membrane lipidsreactive oxygen species (ROS)reactive nitrogen species (RNS)
02

Mechanism of action

Antioxidants scavenge free radicals to prevent lipid peroxidation; Inhibitors of GPX4 or system Xc- (SLC7A11) promote accumulation of lipid peroxides leading to ferroptotic cell death

03

Biological functions

Structural integrity of cell membranesregulation of fluiditycompartmentalizationsignaling (lipid mediators)substrate for lipid peroxidationMediators of oxidative stress and redox signalingcan induce cell death (e.g., via lipid peroxidation and ferroptosis, a form of regulated necrosis)
04

Disease associations

Neurodegenerative diseasesCardiovascular diseasesCancerInflammationAging
05

Safety considerations

Interventions targeting lipid peroxidation or redox balance can disrupt physiological signalingNonspecific antioxidant therapy may impair normal cell functionsinhibition/induction of ferroptosis carries risk of off-target tissue damage
06

Interacting drugs

Antioxidants (e.g., vitamin E, ferrostatin-1, liproxstatin-1 protect membrane lipids from free radical damage)

1 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)Isoprostanes

Beyond the preview

Go deeper on Membrane lipids and Free radicals.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane lipids and Free radicals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call